Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019
March 07 2019 - 4:01PM
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the
Company will release results for its fourth quarter of 2018 ended
December 31, 2018, after the market closes on Tuesday, March 12,
2019, and will hold a conference call to discuss its financial
results at 2:00 p.m. Pacific Time.
To access the conference call, dial toll free (877)
881-2595, or (315) 625-3083 for international callers, five minutes
before the conference. The passcode for the conference call is
4878419.
The call can also be accessed on the Investors page
on the Company’s website www.amphastar.com.
Amphastar is a specialty pharmaceutical company that primarily
develops, manufactures, markets, and sells generic and proprietary
injectable and inhalation products, including products with high
technical barriers to market entry. Most of the Company’s products
are used in hospital or urgent care clinical settings and are
primarily contracted and distributed through group purchasing
organizations and drug wholesalers.
All statements on this conference call that are not historical
are forward-looking statements, including, among other things,
statements relating to the Company’s expectations regarding future
financial performance, backlog, sales and marketing of its
products, market size and growth, the timing of FDA filings or
approvals, including the DMFs of ANP, the timing of product
launches, acquisitions and other matters related to its pipeline of
product candidates, its share buyback program and other future
events. These statements are not historical facts but rather are
based on Amphastar’s historical performance and its current
expectations, estimates, and projections regarding Amphastar’s
business, operations and other similar or related factors. Words
such as “may,” “might,” “will,” “could,” “would,” “should,”
“anticipate,” “predict,” “potential,” “continue,” “expect,”
“intend,” “plan,” “project,” “believe,” “estimate,” and other
similar or related expressions are used to identify these
forward-looking statements, although not all forward-looking
statements contain these words. You should not place undue reliance
on forward-looking statements because they involve known and
unknown risks, uncertainties, and assumptions that are difficult or
impossible to predict and, in some cases, beyond Amphastar’s
control. Actual results may differ materially from those in
the forward-looking statements as a result of a number of factors,
including those described in Amphastar’s filings with the
Securities and Exchange Commission. You can locate these reports
through the Company’s website at http://ir.amphastar.com and on the
SEC’s website at www.sec.gov. Amphastar undertakes no
obligation to revise or update information in this press release or
the conference call referenced above to reflect events or
circumstances in the future, even if new information becomes
available or if subsequent events cause Amphastar’s expectations to
change.
Contact:
William J. PetersChief Financial Officer(909) 980-9484
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Apr 2023 to Apr 2024